Immune Checkpoint Blockade Improves Chemotherapy in the PyMT Mammary Carcinoma Mouse Model

Despite the success of immune checkpoint blockade in cancer, the number of patients that benefit from this revolutionary treatment option remains low. Therefore, efforts are being undertaken to sensitize tumors for immune checkpoint blockade, which includes combining immune checkpoint blocking agent...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Sirait-Fischer, Evelyn, Olesch, Catherine, Fink, Annika F., Berkefeld, Matthias, Huard, Arnaud, Schmid, Tobias, Takeda, Kazuhiko, Brüne, Bernhard, Weigert, Andreas
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7513675/
https://ncbi.nlm.nih.gov/pubmed/33014872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01771
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia